TearScience Names Joseph Boorady CEO

By Staff
Monday, March 02, 2015 12:24 AM MORRISVILLE, N.C.— TearScience, a privately held medical device company, has named Joseph Boorady president and CEO. Dr. Boorady joins TearScience from Carl Zeiss Meditec, Inc. where he was senior vice president of U.S. sales, marketing, and customer service for all medical products.

Safilo Names Kevin Hyland New North American Sport Channel Commercial Leader

By Staff
Monday, March 02, 2015 12:21 AM PADUA, ITALY— Safilo Group has appointed Kevin Hyland as North American sport channel sales leader. Hyland will be responsible for channel sales of the Group’s sports and outdoor lifestyle brands like Suncloud by Polaroid, Smith Optics and future brands in this segment, the company said.

Bortuzzo to Head Kering Eyewear in the Americas

By Staff
Friday, February 27, 2015 12:27 AM NEW YORK—Long-time optical eyewear industry executive, Antonio Bortuzzo, has joined Kering Eyewear, a division of luxury fashion company Kering (FR 0000121485, KER.PA, KER.FP) as the head of the Americas for the company, VMail has learned.

Marcolin Opens Sweden Office

By Staff
Friday, February 27, 2015 12:18 AM LONGARONE, Italy— Marcolin SpA has announced the opening of a branch in Sweden, based in Frösundaviks (Stockholm).

FDA Adds Three Companies to Red List

By Staff
Friday, February 27, 2015 12:15 AM ALEXANDRIA, Va.—The Food and Drug Administration (FDA) has recently updated Import Alert 86-07 with three new companies from China, according to the Vision Council.

Marchon Eyewear Signs License With MCM

By Staff
Monday, February 23, 2015 12:27 AM MELVILLE, N.Y.— Marchon Eyewear, Inc. and MCM (Modern Creation München), a global manufacturer of luxury leather goods, have announced an exclusive multi-year global licensing agreement for the manufacture and distribution of sun and ophthalmic collections under the MCM brand.

Actavis to Change Name to Allergan Following Acquisition

By Staff
Friday, February 20, 2015 12:24 AM DUBLIN, Ireland— Actavis (NYSE: ACT) will change its corporate name to Allergan after it completes its acquisition of Allergan, according to a corporate announcement released on Feb. 18, 2015.

Marcolin Renews Timberland License

By Staff
Friday, February 20, 2015 12:18 AM LONGARONE, Italy— Marcolin SpA and TBL Licensing LLC have announced the early renewal of their licensing agreement for the design, production and worldwide distribution of the Timberland optical frame and sunglass collections.

NovaBay Signs Distribution Agreement With Cardinal Health

By Staff
Monday, February 09, 2015 12:24 AM EMERYVILLE, Calif.—Biopharmaceutical company, NovaBay Pharmaceuticals, Inc.(NYSE MKT: NBY) has signed a distribution agreement with Cardinal Health (NYSE: CAH).

Eastern States to Distribute Été Lunettes in U.S.

By Staff
Friday, February 06, 2015 12:18 AM NEW YORK—Per an agreement with the Italy-based Key Optical Europe, Eastern States Eyewear (ESE) has announced that the exclusive American distribution for Été Lunettes.

Iraj Kamili Appointed to General Manager of De Rigo Vision USA

By Staff
Monday, February 02, 2015 12:27 AM LONGARONE, Italy— De Rigo Vision SpA has announced the appointment of Iraj Kamili to general manager of De Rigo Vision USA.

TearLab Appoints Kong as Vice President of Sales

By Staff
Friday, January 30, 2015 12:21 AM SAN DIEGO— TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) has appointed Raymond Kong to its senior management team as vice president of sales.

Kirk & Kirk Partners With Luxe-Lab for U.S. and Canadian Distribution

By Staff
Wednesday, January 28, 2015 12:18 AM LONDON— Kirk & Kirk has announced that Anaheim, Calif.-based Luxe-Lab will distribute their Vivarium and Solarium collections in the U.S. and Canada.

Tifosi Optics Adds Sales Management and Creative Executives

By Staff
Monday, January 26, 2015 12:24 AM WATKINSVILLE, Ga.— Tifosi Optics, Inc. has announced two new additions to its national sales management team, as well as a new creative director to head up the company’s creative development and graphics.

Hanmi Invests $20M in Allegro and Licenses Its AMD, DME and VMT Therapy in Korea and China

By Staff
Monday, January 26, 2015 12:21 AM SAN JUAN CAPISTRANO, Calif., and SEOUL, Korea— Allegro Ophthalmics, LLC, and Hanmi Pharmaceuticals Co., Ltd., have entered into a license agreement for Luminate (ALG-1001), Allegro’s Integrin Peptide Therapy, in The Republic of Korea and the People’s Republic of China, according to a statement released earlier this month by Allegro, based in San Juan Capistrano, Calif.
Loading...